SANTA CLARA, Calif., August 20, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion ...

Biocartis Group of Companies (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that its Idylla™ CDx MSI Test developed in partnership with Bristol Myers Squibb, has ...

The latest update is out from Pacific Edge Limited ( (PFGTF) ).

Researchers from Johns Hopkins Kimmel Cancer Centre, Johns Hopkins All Children's Hospital, and other institutions have ...

Researchers have developed a blood-based test that shows high accuracy for diagnosing ALS as early as up to 10 years before symptom onset.

Blood tests have long been an important tool for giving doctors a picture of a patient’s health, from cholesterol levels to diabetes risk. Now new genetic science, AI analysis and other advances are ...

Biocartis Receives FDA Approval for the Idylla™ CDx MSI TestFirst-ever fully automated, sample-to-result, cartridge-based companion diagnostic test approved in the US for colorectal cancer ...